CIN/LLPIN/FCRN | U24239TG2005PLC048151 |
ROC Name | ROC Hyderabad |
Company Type | Company |
Company Category | Company limited by shares |
Activity Description | |
Active Compliance | - |
Date of Inc | 23 November, 2005 |
Date of AGM | 30 September, 2023 |
Date of B/S | 31 March, 2023 |
Company Status | Active |
CIRP | - |
Address other than R/o | - |
Authorise Capital | 5,00,00,000 |
Paid up capital | 4,20,92,640 |
c******@r*****************.com | |
Listing Status | Not Listed |
filling status | - |
Pan | - |
Registered Address | 425/3RT, D.No, 7-1-621/328, Sanjeev Reddy Nagar,, HYDERABAD, , Telangana - 500038, India |
Sr No | DIN | Name | Designation | Begin Date |
---|---|---|---|---|
1 | 00105360 | ARUNA KUMARI CHANDANA | Director | 23 November, 2005 |
2 | 01717688 | PALEM SRINIVAS | Managing Director | 07 March, 2009 |
3 | 08700919 | VEERA VENKATA VARA PRASAD VEERNI | Director | 31 December, 2020 |
4 | 08700926 | BHAVANI SANKAR ALLA | Director | 31 December, 2020 |
5 | 00105304 | ANJANEYA PATTABHI RAMESWARA RAO CHANDANA | Director | 25 March, 2014 |
The CIN (Corporate Identification Number) for RAKSHIT PHARMACEUTICALS LIMITED is U24239TG2005PLC048151.
RAKSHIT PHARMACEUTICALS LIMITED is registered with ROC Hyderabad.
RAKSHIT PHARMACEUTICALS LIMITED is a Company limited by shares.
The main activity of RAKSHIT PHARMACEUTICALS LIMITED is .
RAKSHIT PHARMACEUTICALS LIMITED was incorporated on 23 November, 2005.
RAKSHIT PHARMACEUTICALS LIMITED is currently Active.
The authorized capital of RAKSHIT PHARMACEUTICALS LIMITED is ₹5,00,00,000.
The paid-up capital of RAKSHIT PHARMACEUTICALS LIMITED is ₹4,20,92,640.
No, RAKSHIT PHARMACEUTICALS LIMITED is not listed on stock exchange.
The registered address of RAKSHIT PHARMACEUTICALS LIMITED is 425/3RT, D.No, 7-1-621/328, Sanjeev Reddy Nagar,, HYDERABAD, , Telangana - 500038, India
There are 5 directors in RAKSHIT PHARMACEUTICALS LIMITED. ARUNA KUMARI CHANDANA, PALEM SRINIVAS, VEERA VENKATA VARA PRASAD VEERNI, BHAVANI SANKAR ALLA, and ANJANEYA PATTABHI RAMESWARA RAO CHANDANA.